Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials

BMJ 2012; 344 doi: http://dx.doi.org/10.1136/bmj.d7771 (Published 11 January 2012)
Cite this as: BMJ 2012;344:d7771

Related articles

Research: Incretin treatment and risk of pancreatitis in patients with type 2 diabetes mellitus: systematic review and meta-analysis of randomised and non-randomised studies

Letter: Authors’ reply to de Oliveira and Iverson

Letter: Utility of GLP-1R agonists in diabetes requires long term study

Letter: GLP-1R agonists are not a quick fix for weight loss

Editorial: Glucagon-like peptide-1 agonists

Research: Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study

Research: Long term pharmacotherapy for obesity and overweight: updated meta-analysis

RESEARCH: Long term pharmacotherapy for obesity and overweight: updated meta-analysis

See more

Research News: Diabetes complication rates fall markedly in the US, says CDC study

Practice: Drowning

Research News: Impact of polypill difficult to demonstrate from varied studies, say Cochrane reviewers

Editor's Choice: The pressures of pregnancy

Research: Chronic hypertension and pregnancy outcomes: systematic review and meta-analysis

This article has been cited by other articles:

THIS WEEK'S POLL